MB, Levis & Associates’s Amicus Therapeutics FOLD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.73K | Buy |
1,000
+500
| +100% | +$2.87K | ﹤0.01% | 213 |
|
|
2025
Q1 | $4.08K | Hold |
500
| – | – | ﹤0.01% | 225 |
|
|
2024
Q4 | $4.71K | Sell |
500
-1,000
| -67% | -$9.42K | ﹤0.01% | 219 |
|
|
2024
Q3 | $16K | Hold |
1,500
| – | – | 0.01% | 171 |
|
|
2024
Q2 | $14.9K | Hold |
1,500
| – | – | 0.01% | 170 |
|
|
2024
Q1 | $17.6K | Hold |
1,500
| – | – | 0.01% | 161 |
|
|
2023
Q4 | $21.3K | Hold |
1,500
| – | – | 0.01% | 151 |
|
|
2023
Q3 | $18.2K | Hold |
1,500
| – | – | 0.01% | 163 |
|
|
2023
Q2 | $18.8K | Hold |
1,500
| – | – | 0.01% | 161 |
|
|
2023
Q1 | $16.6K | Hold |
1,500
| – | – | 0.01% | 168 |
|
|
2022
Q4 | $18.3K | Buy |
+1,500
| New | +$18.3K | 0.01% | 155 |
|